NCT06433336Completed
Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 29 May 2024
Brief summary (registry, in English)
Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patients with atrial fibrillation
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 800 (actual)
- First submitted
- 22 May 2024
- Start date
- 1 Jan 2019
- Primary completion date
- 21 May 2024
- Lead sponsor
- Lanzhou University Second Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06433336
What you commit to
- Study type: Observational
- Participants enrolled: 800
- From 1 Jan 2019 to the primary completion date, 21 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No follow-up
Who the study is looking for
- The inclusion criteria were age \>18 years and a diagnosis of AF by electrocardiogram during the preceding six months or on admission
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lanzhou University Second Hospital Coordinator of this site? Confirm its status | Lanzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.